In the classic business model, pharmaceutical companies recuperate research and development investments selling large volumes of their medicinal products.
U okviru uobičajenog poslovnog modela farmaceutska društva prodajom velikih količina svojih lijekova nadoknađuju troškove ulaganja u istraživanja i razvoj.